RANI (Rani Therapeutics Holdings) Bozor qiymatining balans qiymatiga nisbati

ranitherapeutics.com (RANI) kompaniyasining rasmiy ramzlari

Rani Therapeutics (RANI) dunyodagi eng yirik korporativ texnologik gigantlar inyeksiyali dori vositalariga alternativlarni joriy etish huquqi uchun raqobatlashadigan o'ta agressiv muhitda faoliyat yuritadi. Grafikdagi 1.74 qiymatiga ega narx ko'rsatkichi, masshtablanishi FDA tasdig'ini olishdan oldin ulkan muhandislik xarajatlari bilan cheklangan biznes dinamikasini aks ettiradi. Shu bilan birga, rahbariyat chuqur texnik bilimga ega bo'lib, innovatsion RaniPill tizimini ishlab chiqish uchun kapital xarajatlarini samarali boshqarmoqda.

RANI ranitherapeutics.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Rani Therapeutics (RANI) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi ranitherapeutics.com|RANI - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Rani Therapeutics Inc|RANI - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Rani Therapeutics|RANI - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ranitherapeutics.com|RANI - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Rani Therapeutics|RANI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati ranitherapeutics.com|RANI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Rani Therapeutics Inc|RANI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Rani Therapeutics
Kompaniyaning dastlabki tahlili:Rani Therapeutics Holdings - RANI
ranitherapeutics.com original mahsuloti

Ushbu koeffitsiyent joriy aksiya narxini kompaniyaning sof aktivlariga solishtirib, biznesning bozor qiymati haddan tashqari yuqori yoki past baholanganlik darajasini ochib beradi. Qiymat moliyaviy hisobotlar e'lon qilinganda balans hisoboti tuzatishlariga sezgir bo'ladi. Bozor kapitalizatsiyasining kitob qiymatiga nisbatini tahlil qilish aktivga kirish nuqtasini aniqlashga yordam beradi. Rani Therapeutics (RANI) uchun ushbu metrika uning patentlangan robotlashtirilgan kapsulalarini tijoratlashtirishga bozorning ishonchini aks ettiradi. Bu yerdagi yuqori koeffitsient uning innovatsion biologik yetkazib berish platformasini joriy etishdan kelajakda royalti to'lovlari tushishi haqidagi kutishlarni tasdiqlaydi.

Asosiy raqobatchilar

Haleon plc - Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|Bozor qiymatining balans qiymatiga nisbati MindWalk Holdings Inc.|Balans qiymatiga nisbatan bozor qiymati ABVC BioPharma Inc. ABVC|Cumberland Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|QNTM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati FibroGen, Inc.|telomirpharma.com (TELO) - Kapitallashuvning balans qiymatiga nisbati|SNYR: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Rallybio Corp. (RLYB)|Lexaria Bioscience (LEXX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Pulmatrix Corporation PULM|Kapitallashuvning sof aktivlarga nisbati Pheton Holdings (PTHL)|Bozor kapitallashuvining balans qiymatiga multiplikatori Aptorum Group Ltd APM|Bozor kapitallashuvining balans qiymatiga nisbati Lyra Therapeutics (LYRA)|IBO - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TNFA|YCBD (cbdMD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PRFX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OPTN (OptiNose Inc)|Pieris (PIRS) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Procaps Group Corp PROC|PTPI (Petros Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SLRN: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TFF Pharmaceuticals Inc.